Ascend Wellness Holdings (AAWH) Interest Expenses (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Interest Expenses of $725.5 million for Q1 2026, up 4324.08% year-over-year from $16.4 million in Q1 2025, and up 3052.5% quarter-over-quarter from $23.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Interest Expenses (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Interest Expenses history runs 7 years deep, the most recent figure standing at $725.5 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 4324.08% year-over-year to $725.5 million; the TTM figure through Mar 2026 stood at $725.5 million (up 1200.71% YoY), while the FY2025 annual figure was $51.3 million, up 13.32% from the prior year.
- Interest Expenses for Q1 2026 stood at $725.5 million, up from $23.0 million in the prior quarter.
- The five-year high for Interest Expenses was $725.5 million in Q1 2026, with the low at $6.8 million in Q1 2022.
- The 5-year median for Interest Expenses is $10.5 million (2023), against an average of $89.2 million.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses slumped 81.7% in 2022, then surged 7053.85% in 2025.
- Ascend Wellness Holdings' Interest Expenses stood at $8.7 million in 2022, then soared by 100.63% to $17.5 million in 2023, then declined by 17.94% to $14.4 million in 2024, then jumped by 60.22% to $23.0 million in 2025, then jumped by 3052.5% to $725.5 million in 2026.
- Business Quant data shows AAWH's Interest Expenses at $725.5 million in Q1 2026, $23.0 million in Q4 2025, and $12.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ascend Wellness Holdings | 97.42 Mn | 30.42 Mn | 45.49 Mn | 20.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 732.13 Mn |
| Jun 30, 2026 | 732.13 Mn |
| Mar 31, 2026 | 725.55 Mn |
| Mar 31, 2026 | 725.55 Mn |
| Dec 31, 2025 | 23.02 Mn |
| Dec 31, 2025 | 23.02 Mn |
| Sep 30, 2025 | 12.56 Mn |
| Sep 30, 2025 | 12.56 Mn |
| Jun 30, 2025 | 610.58 Mn |
| Jun 30, 2025 | 610.58 Mn |
| Mar 31, 2025 | 16.40 Mn |
| Mar 31, 2025 | 16.40 Mn |
| Dec 31, 2024 | 14.37 Mn |
| Dec 31, 2024 | 14.37 Mn |
| Sep 30, 2024 | 16.48 Mn |
| Sep 30, 2024 | 16.48 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Mar 31, 2024 | 10.03 Mn |